Searched for
MOLNUPIRAVIR INDIA
Molnupiravir reduced Covid-linked hospitalisation by over 65%: StudyThe Phase III trial results of Hetero's Movfor (Molnupiravir), presented at the Conference on Retroviruses and Opportunistic Infections (CR...- With limited options, doctors and hospitals start prescribing Molnupiravir for high-risk patientsThe latest surge of Covid cases is largely fuelled by the Omicron variant, even as the Delta is spreading albeit at a lower intensity.
- India to become hub for Covid-19 antiviral generic drugs: FitchGeneric molnupiravir will increase access in India and other low- and middle-income countries (LMICs), while simplifying current supply cha...
- Lupin launches Molnulup for COVID-19 treatmentMolnupiravir has been given emergency use authorisation by the Drug Controller General of India (DCGI) for treatment of adult COVID-19 pati...
- Merck says no safety concerns observed in molnupiravir phase-3 trial, shared relevant data with DCGIMerck Sharp & Dohme (MSD) on Friday said its COVID antiviral molnupiravir has cut the risk of hospitalization or death in Phase 3 clinical ...
- Aurobindo Pharma launches COVID-19 drug Molnupiravir in IndiaMolnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions, a press release from the city-based d...
- Mankind Pharma set to roll out cheapest coronavirus drugThe full treatment of Molulife (brand name) is expected to cost ₹1,400, RC Juneja, chairman of Mankind Pharma, told ET. The brand is expect...
- A full Molnupiravir treatment likely to cost up to Rs 3,000The recommended dose of molnupiravir is 800 mg twice a day for five days. With companies planning to launch 200 mg capsules, a patient will...
- Dr Reddy's Laboratories to introduce Molnupiravir to treat COVID-19 shortlyThe drug firm said it is able to manufacture the active pharmaceutical ingredient (API) as well as the formulation for Molnupiravir, and ha...
- Companies race to make COVID antiviral drug molnupiravir available in pharmaciesDrug maker Cipla said it will soon make molnupiravir capsules available at all leading pharmacies and Covid treatment centers across the co...
- Torrent Pharma to launch Molnupiravir under Molnutor brand name to treat COVID-19Torrent Pharmaceuticals on Tuesday said it will launch MSD and Ridgeback's molnupiravir under the brand name Molnutor in India for the trea...
- Sun Pharma gets DCGI nod to market molnupiravir for COVID-19 treatmentEarlier this year, the Mumbai-based drug major had signed a non-exclusive voluntary licensing agreement with MSD to manufacture and supply ...
- A game-changing pill and two new vaccines will bolster India's fight against Covid variantsThe recommendations have been sent to the Drug Controller General of India (DCGI), which will soon decide on their approval, people in the ...
- Sun Pharma says gearing up to launch COVID drug molnupiravirThe company said the Drugs Controller General of India (DCGI) is currently reviewing clinical data of molnupiravir for the treatment of COV...
- Natco Pharma, Hetero seek marketing authorisation for anti-Covid drug molnupiravirNatco has conducted Phase III trials of molnupiravir and submitted the trial results to the drug regulator this month. "We have submitted p...
- MSD enters pact with UN-backed MPP to license COVID drug molnupiravir in 105 countries including IndiaUnder the terms of the agreement, MPP will be permitted to further license non-exclusive sub-licences to manufacturers and diversify the ma...
- MSD in talks with Medicines Patent Pool for additional licenses for molnupiravirMSD entered into a voluntary licensing agreement with five Indian drug makers including Sun Pharma, Cipla, Dr. Reddy’s, Emcure and Hetero f...
- MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufactur...
- Natco Seeks emergency approval to launch Molnupiravir for Covid-19 in IndiaMolnupiravir was originally developed to treat influenza before US-based Merck initiated research to repurpose drug for use against SARS-Co...
- Natco seeks emergency nod for Molnupiravir to treat CovidThe development comes close on the heels of findings announced by the researchers that Molnupiravir was found effective for treating the pa...
Load More
